Insider Selling: Tempus AI, Inc. (NASDAQ:TEM) Director Sells 1,320 Shares of Stock

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) Director Jennifer A. Doudna sold 1,320 shares of the stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $90.00, for a total transaction of $118,800.00. Following the completion of the sale, the director now directly owns 36,011 shares of the company's stock, valued at $3,240,990. This trade represents a 3.54 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Tempus AI Stock Performance

Tempus AI stock traded up $5.69 on Monday, reaching $89.44. The company's stock had a trading volume of 25,048,636 shares, compared to its average volume of 12,947,475. Tempus AI, Inc. has a twelve month low of $22.89 and a twelve month high of $91.45. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. The business's fifty day moving average price is $46.60 and its 200 day moving average price is $50.37.

Analysts Set New Price Targets

A number of brokerages have recently commented on TEM. Stifel Nicolaus lowered Tempus AI from a "buy" rating to a "hold" rating and increased their price objective for the company from $45.00 to $65.00 in a report on Monday, November 11th. Loop Capital dropped their price target on shares of Tempus AI from $57.00 to $52.00 and set a "buy" rating on the stock in a research report on Tuesday, January 14th. Piper Sandler reaffirmed a "neutral" rating and set a $70.00 price objective (up from $40.00) on shares of Tempus AI in a report on Tuesday, November 12th. TD Cowen reiterated a "buy" rating and issued a $74.00 target price (up previously from $58.00) on shares of Tempus AI in a report on Wednesday, February 5th. Finally, Needham & Company LLC restated a "buy" rating and set a $56.00 price target on shares of Tempus AI in a report on Tuesday, January 14th. Four analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat.com, Tempus AI presently has a consensus rating of "Moderate Buy" and a consensus target price of $58.55.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the stock. Kovitz Investment Group Partners LLC bought a new position in shares of Tempus AI in the 3rd quarter valued at about $1,367,000. China Universal Asset Management Co. Ltd. acquired a new position in Tempus AI in the fourth quarter valued at approximately $1,091,000. Sumitomo Mitsui Trust Group Inc. boosted its stake in Tempus AI by 1,591.2% in the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,217,699 shares of the company's stock valued at $68,922,000 after acquiring an additional 1,145,698 shares during the last quarter. Captrust Financial Advisors acquired a new stake in Tempus AI during the 3rd quarter worth $2,726,000. Finally, Mirae Asset Global Investments Co. Ltd. bought a new stake in shares of Tempus AI during the 4th quarter valued at $178,000. Institutional investors own 24.22% of the company's stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.